000 | 01741 a2200481 4500 | ||
---|---|---|---|
005 | 20250518015234.0 | ||
264 | 0 | _c20201002 | |
008 | 202010s 0 0 eng d | ||
022 | _a1559-1174 | ||
024 | 7 |
_a10.1007/s12017-018-08523-5 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aBahn, Gahee | |
245 | 0 | 0 |
_aTherapeutic Approaches to Alzheimer's Disease Through Modulation of NRF2. _h[electronic resource] |
260 |
_bNeuromolecular medicine _c03 2019 |
||
300 |
_a1-11 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review | ||
650 | 0 | 4 |
_aAging _xgenetics |
650 | 0 | 4 |
_aAlzheimer Disease _xdrug therapy |
650 | 0 | 4 |
_aAmyloid beta-Peptides _xmetabolism |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 | _aAntioxidant Response Elements |
650 | 0 | 4 |
_aBasic-Leucine Zipper Transcription Factors _xmetabolism |
650 | 0 | 4 | _aDisease Models, Animal |
650 | 0 | 4 |
_aGene Expression Regulation _xdrug effects |
650 | 0 | 4 | _aGenetic Therapy |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMice |
650 | 0 | 4 | _aMice, Knockout |
650 | 0 | 4 | _aMice, Transgenic |
650 | 0 | 4 |
_aMolecular Targeted Therapy _xmethods |
650 | 0 | 4 |
_aNF-E2-Related Factor 2 _xagonists |
650 | 0 | 4 |
_aNerve Tissue Proteins _xagonists |
650 | 0 | 4 |
_aOxidative Stress _xdrug effects |
650 | 0 | 4 | _aProtein Domains |
650 | 0 | 4 |
_aSignal Transduction _xdrug effects |
650 | 0 | 4 |
_aTauopathies _xdrug therapy |
650 | 0 | 4 |
_aTranscription, Genetic _xdrug effects |
650 | 0 | 4 |
_aUp-Regulation _xdrug effects |
650 | 0 | 4 |
_atau Proteins _xmetabolism |
700 | 1 | _aJo, Dong-Gyu | |
773 | 0 |
_tNeuromolecular medicine _gvol. 21 _gno. 1 _gp. 1-11 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1007/s12017-018-08523-5 _zAvailable from publisher's website |
999 |
_c29229224 _d29229224 |